“For many veterans, the battle does not end when they come home. Too many carry the invisible wounds of service.”
By Ben Solis, Michigan Advance
Can a psychedelic drug with heavy side-effects and anecdotal evidence as a treatment for addiction become a wonder drug for veterans facing opioid substance abuse and post-traumatic stress disorders?
House Republican state Rep. Jaime Green of Richmond wants to find out, and she wants to use opioid settlement dollars to fund necessary clinical trials—a proposal that might meet some resistance from her Democratic colleagues.
Members of the House Families and Veterans Committee discussed Greene’s House Bill 6020 on Tuesday. The committee included testimony from proponents of ibogaine as a therapeutic addiction and trauma drug.
The committee took testimony only and did vote on Greene’s bill.
Ibogaine is currently outlawed in the United States and is considered a Schedule I controlled substance. It is a potent psychedelic with a prolonged experience sometimes lasting more than 12 hours.
Those who testified on Tuesday said the drug is physically and mentally intense, as an ibogaine experience has been likened to Indigenous ancient spirit journeys with waking visions. It also carries heavy cardiovascular risks, and requires attentive medical monitoring by licensed
Read full article on Marijuana Moment
